Safety and recommendation of voriconazole for invasive pulmonary aspergillosis in severe liver disease patients: a retrospective cohort study
Voriconazole monotherapy demonstrated good tolerability with lower mortality in SLD patients with IPA. A no-loading dose voriconazole regimen is proposed for IPA treatment in SLD patients, yet pharmacokinetic studies combined with prospective studies are needed for further validation.
Authors
- Xue Chen (ORCID: https://orcid.org/0000-0002-1282-3405)
- Yuqing Sun (ORCID: https://orcid.org/0000-0002-0625-6096)
- Ling Zhang (ORCID: https://orcid.org/0000-0002-5160-8900)
- Yulin Zhang (ORCID: https://orcid.org/0000-0002-1214-594X)
- Caopei Zheng
- Lijun Pang
- Xin Zhang (ORCID: https://orcid.org/0000-0001-6388-9327)
Institutions
- Capital Medical University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Beijing YouAn Hospital (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1186/s12879-025-10459-8
- Citations
- 2
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 2.79